Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The study history now shows enrollment is closed and a new revision tag (v3.6.0) was added, replacing the previous revision (v3.5.5) to reflect an updated version of the record.
    Difference
    0.2%
    Check dated 2026-06-12T14:55:35.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    Revision: v3.5.5 replaces v3.5.4 in the page's history, indicating an update to the page's version metadata. This update does not modify the study data or visible content.
    Difference
    0.1%
    Check dated 2026-06-05T10:31:20.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    New entries for Contacts/Locations and Study Status were added to the study history. An older change entry dated 2025-12-02 was removed.
    Difference
    0.3%
    Check dated 2026-05-22T08:43:43.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    An official new revision entry v3.5.4 was added to the study record history. The previous revision v3.5.3 was removed, indicating an update to the record.
    Difference
    0.1%
    Check dated 2026-05-15T02:27:23.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page’s revision line has been updated from v3.5.2 to v3.5.3. This reflects a new release version in the site history without altering study content.
    Difference
    0.1%
    Check dated 2026-04-30T18:53:00.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision v3.5.2 was added to the history, and Revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:08:04.000Z thumbnail image

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.